Edition:
India

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
88,017
52-wk High
$5.17
52-wk Low
$0.80

Chart for

About

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's... (more)

Overall

Beta: 2.23
Market Cap(Mil.): $14.62
Shares Outstanding(Mil.): 15.07
Dividend: --
Yield (%): --

Financials

BRIEF-Aethlon Medical Names Dr. Charles J. Fisher Chairman Of The Board

* AETHLON MEDICAL NAMES DR. CHARLES J. FISHER CHAIRMAN OF THE BOARD Source text for Eikon: Further company coverage:

29 Nov 2017

BRIEF-Aethlon Medical announces second quarter results

* Aethlon Medical announces fiscal 2018 second quarter results

03 Nov 2017

BRIEF-AETHLON MEDICAL ANNOUNCES PRODUCTION COLLABORATION WITH IBIO INC

* AETHLON MEDICAL ANNOUNCES LARGE-SCALE PRODUCTION COLLABORATION

16 Oct 2017

BRIEF-IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL

* IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL

16 Oct 2017

BRIEF-Intracoastal Capital reports 5.7 pct passive stake in Aethlon Medical

* Intracoastal Capital LLC reports 5.7 percent passive stake in Aethlon Medical Inc as of Oct 2 - SEC filing‍​ Source : (http://bit.ly/2ybZng4) Further company coverage:

12 Oct 2017

BRIEF-Aethlon Medical Receives expedited access pathway designation from FDA

* Aethlon Medical receives expedited access pathway designation from FDA to accelerate U.S. access to the hemopurifier as a treatment for life-threatening viruses Source text for Eikon: Further company coverage:

12 Sep 2017

BRIEF-Aethlon Medical received formal receipt from FDA for expedited access pathway program submission ‍​

* On Aug 14, co received formal receipt from the U.S. FDA for expedited access pathway program submission ‍​

15 Aug 2017

BRIEF-Aethlon Medical reports Q1 loss per share $0.21

* Aethlon Medical announces fiscal 2018 first quarter results

11 Aug 2017

BRIEF-Aethlon Medical Inc files for stock offering of up to $13.3 mln - SEC filing

* Aethlon Medical Inc files for common stock offering of up to $13.3 million - SEC filing Source text: (http://bit.ly/2vgQRdw) Further company coverage:

01 Aug 2017

BRIEF-Aethlon Medical ‍announces grant of U.S. patent

* Aethlon Medical Inc - ‍announces grant of a U.S. Patent protecting methods of capturing MHC antigen associated exosomes​ Source text for Eikon: Further company coverage:

19 Jul 2017

Earnings vs. Estimates